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PURPOSE. Trachoma is a conjunctival scarring disease, which is the leading infectious cause
of blindness worldwide. Elimination of blinding trachoma is being held back by the high
rate of trichiasis recurrence following surgery. There is currently no treatment available to
suppress the profibrotic state and reduce recurrence. Although the mechanisms
underlying trichiasis development are unknown, the profibrotic phenotype has been
linked to matrix metalloproteinase (MMP) expression. Doxycycline, a well-known
tetracycline antibiotic, can act as a broad MMP inhibitor and has showed some success
in preventing fibrosis in various clinical contexts. The purpose of this work was to assess
the antiscarring properties of doxycycline in an in vitro model of trichiasis fibroblast–
mediated tissue contraction.
METHODS. Primary cultures of fibroblasts were established from conjunctival samples obtained
from normal donors or during surgery for trachomatous trichiasis. The effect of doxycycline
on matrix contraction was investigated in our standard collagen gel contraction model. Cell
morphology and matrix integrity were assessed using confocal reflection microscopy.
Quantitative real time polymerase chain reaction and a FRET-based assay were used to
measure MMP expression and activity, respectively.
RESULTS. Doxycycline treatment successfully suppressed the contractile phenotype of
trichiasis fibroblasts, matrix degradation, and significantly altered the expression of MMP1,
MMP9, and MMP12 associated with the profibrotic phenotype.
CONCLUSIONS. In view of the results presented here and the wider use of doxycycline in clinical
settings, we propose that doxycycline might be useful as a treatment to prevent recurrence
following trichiasis surgery.
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Trachoma is the leading infectious cause of blindnessworldwide.1 The disease begins with recurrent infection
by the bacterium Chlamydia trachomatis in early childhood,
promoting chronic inflammation of the upper tarsal conjunc-
tiva, which leads to progressive scarring and distortion of the
eyelid. The edge of the eyelid turns in (entropion), so that the
lashes scratch the surface of the eye (trichiasis). This can result
in corneal opacity and irreversible sight loss.2 Trachoma is a
public health problem in over 50 countries, predominantly in
Sub-Saharan Africa, the Middle East, the Indian subcontinent,
Southeast Asia, and South America.3 The most recent global
estimation from the World Health Organization (WHO) suggests
that 40 million people currently have active trachoma, a further
8.2 million have trichiasis, and 1.3 million are estimated to be
blind as a result.1 The WHO is leading a global alliance to
eliminate blinding trachoma by 2020. This focuses on the
implementation of the SAFE strategy: surgery for trichiasis,
antibiotics for infection, facial cleanliness, and environmental
improvements to reduce transmission of infection. However,
there is growing evidence that the scarring complications can
progress even in the absence of detectable chlamydial
infection,4 and following trichiasis surgery, the anatomical
abnormality can redevelop (from 10% at 1 year to 60% at 3
years), in part through an ongoing immunofibrogenic pro-
cess.5,6 There is currently no adjuvant treatment available to
suppress the profibrotic state and reduce recurrence.
The mechanisms underlying postsurgical recurrence of
trichiasis are not fully understood. However, the dysregulated
extra cellular matrix (ECM) proteolysis observed following
infection and inflammation is suggested to play a key role in the
development of fibrotic sequelae.6 MMPs are a tightly regulated
family of zinc-dependent enzymes responsible for degrading
structural proteins of the ECM, and are produced by a variety of
cell types after injury.7 A number of MMPs have been found to
associate with conjunctival scarring in in vitro models,8 as well
as in vivo.9 MMP9 expression increases when conjunctival
inflammation is associated with non-chlamydial bacterial
infection in recurrent trichiasis,10 and an increased level of
MMP7 gene expression was also identified in trichiasis
conjunctival samples.11 Moreover, microarray analysis has
confirmed the increased expression of MMP7, MMP9, and
MMP12 in conjunctival samples from trichiasis subjects.12
Overall, this suggests that the accumulation of fibrotic tissue in
trichiasis might be due at least in part to altered MMP
expression.
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Doxycycline, a well-known tetracycline antibiotic, is widely
used to prevent and treat bacterial and parasite infection,
including Chlamydia trachomatis. More recently, its role as
MMP inhibitor and in apoptosis has gathered more attention in
the context of vascular disease,13,14 pulmonary fibrosis,15
periodontitis,16 as well as ocular pathology.17–19 Doxycycline
inhibits MMPs, and particularly MMP9, at subantimicrobial doses
in patients.13,14,19,20 In addition, recent work suggests that
doxycycline treatment can dampen local21 as well as systemic22
inflammation, thus making it a good candidate to prevent tissue
remodeling and fibrosis in trachoma. Using for the first time
conjunctival cells directly isolated from trachomatous trichiasis-
affected individuals, we demonstrate that doxycycline signifi-
cantly reduced collagen matrix remodeling and contraction, and
specifically inhibited the mRNA expression of MMP1, MMP7,
MMP9, and MMP12 during contraction, suggesting that it could
be a potential adjuvant treatment following trichiasis surgery.
MATERIALS AND METHODS
Ethics Statement
This study adhered to the tenets of the Declaration of Helsinki.
It was approved by the Tanzanian National Institute of Medical
Research, the Kilimanjaro Christian Medical Centre, and the
London School of Hygiene and Tropical Medicine Ethics
committees. The study was explained to potential study
participants and written informed consent was obtained before
enrollment.
Clinical Samples
Conjunctival biopsies were obtained from the upper tarsal
conjunctiva from Tanzanian patients undergoing trichiasis
surgery. All cases had tarsal conjunctival scarring with
entropion trichiasis. The eyelid was anesthetized with an
injection of 2% lignocaine and the eye cleaned with 5%
povidone iodine. A biopsy sample was taken using a 3-mm
trephine from the tarsal conjunctiva, 2 mm from the lid margin,
at the junction of the medial two-thirds and lateral one-third of
the everted lid. The biopsies were wrapped in sterile gauze,
moistened with normal saline, and transported to the
laboratory at þ88C.
Cell Culture and Reagents
The biopsies were mechanically dispersed and the tissue
fragments were placed in tissue culture dishes in Dulbecco’s
modified Eagle’s medium (DMEM) with 4.5 g/L L-glutamine
(PAA Laboratories, Piscataway, NJ), supplemented with 10%
fetal bovine serum (FBS; Sigma-Aldrich, St. Louis, MO), 100 IU/
mL penicillin, 100 lg/mL streptomycin (Invitrogen, Carlsbad,
CA) at 378C with 5% CO2. Following growth from the explant,
the fibroblast populations (F07, F09, F10, and F11) were
trypsinized and maintained routinely in the above medium. All
four cell lines were tested for C. trachomatis infection using
the Amplicor CT/NG Kit (Roche Molecular Systems, Branch-
burg, NJ) and were found to be negative. The cells were used
between passage 4 and 9 for all experiments. For doxycyline
treatment, a stock solution of 48.7 mM doxycycline hyclate
(Sigma-Aldrich) was made in sterile ultrapure water (Biocel;
Millipore Corp., Billerica, MA) and added to the cell culture
medium at final concentrations of 104 and 416 lM.
Collagen Contraction Assay
The collagen contraction assays were performed as previously
described.8 Trachoma cells were seeded in a 1.5 mg/mL
collagen type-I matrix (First Link [UK], Ltd, Wolverhampton,
UK) at a concentration of 7 3 104 cells/mL. The gels were
detached from the edge of the well, and 2 mL of DMEM with/
without doxycycline was added. Gel contraction was moni-
tored daily for 7 days by digital photography. Gel areas were
measured using Java-based imaging software (ImageJ; provided
in the public domain by the National Institutes of Health [NIH],
Bethesda, MD; http://rsb.info.nih.gov/ij/), and the contraction
was plotted as a percentage of gel area normalized to original
area (day 0 measurement).
Cytotoxicity Assay
Cytotoxicity was determined using a cytotoxicity detection kit
(Cytotoxicity Detection Kit [LDH]; Roche Applied Science,
Penzberg, Upper Bavaria, Germany), on media collected at the
termination of the gel contraction experiment (in phenol red-
free DMEM) to measure the percentage of lactate dehydroge-
nase activity (LDH) present in the samples. The gels were lysed
in 2% Triton X-100 (Sigma-Aldrich) in phenol red free, serum
free DMEM for 10 minutes to achieve the maximum LDH
release. Absorbances were measured at 490 nm (FLUOstar
Optima; BMG LABTECH, Ortenberg, Germany) and the
percentage of cytotoxicity was calculated according to the
manufacturer’s protocol.
Cell and Matrix Imaging
Following contraction for 7 days with/without 416 lM
doxycycline, gels were fixed in 3.7% paraformaldehyde (Sigma-
Aldrich) at room temperature for 30 minutes, followed by
permeabilization with 0.5% Triton X-100 (Sigma-Aldrich) for 30
minutes, and staining with rhodamine-phalloidin (Invitrogen)
for 1 hour.8,23 Imaging was carried out on a confocal laser
scanning microscope (Zeiss Axiovert S100; Carl Zeiss Microsco-
py, LLC, Thornwood, NY; Radiance 2000; Bio-Rad Laboratories,
Inc., Hercules, CA) using simultaneous reflection microscopy
and fluorescence imaging.23 Representative images were
acquired as z-stacks using a long working distance objective
(Carl Zeiss Microscopy, LLC; 633/0.75 Plan-Neofluar with
correction collar). The resulting volumes were imported into
the ImageJ software (NIH) where the fluorescence channel (F-
actin staining) was compressed to a single projection and
merged with a representative section of the matrix.
Quantitative Real-Time PCR
Collagen gel contraction assays were ended at days 0, 3, and 7 by
placing the gels straight into TRIzol (Invitrogen) at 48C for 1 hour.
Control mRNA at day 0 were obtained after 1 hour of initial gel
polymerization. Homogenization and phase separation were
carried out according to the manufacturer’s instructions. The
aqueous phase was harvested and used for RNA isolation using
an RNA purification kit (RNeasy Mini Kit; Qiagen, Hilden,
Germany) according to the standard protocol. Reverse transcrip-
tion was carried out using a reverse transcription kit (QuantiTect
Reverse Transcription Kit; Qiagen) according to manufacturer’s
instructions. MMP gene expression was measured by QRT-PCR
using validated primers and probes (Assay-on-Demand; Applied
Biosystems, Foster City, CA). Assay identification numbers are
MMP1 (Hs00899658_m1); MMP2 (Hs01548727_m1); MMP7
(Hs01042796_m1); MMP9 (Hs00234579_m1); and MMP12
(Hs00899662_m1). The hypoxanthine phosphoribosyl transfer-
ase-1 gene was used as an endogenous control to normalize the
sample concentration. RT-PCR reactions were performed on a
real-time PCR system (HT7900 Fast Real-Time PCR; Applied
Biosystems), and the 2(-Delta Delta C(T)) method was used for
quantification of mRNA levels.
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MMP Activity Assay
Total MMP activity was determined using a FRET-based MMP
activity assay kit according to the manufacturer’s protocol
(ab112147; Abcam, Cambridge, England). In brief, 25 lL of
medium from control and doxycycline-treated collagen gel
contraction cultures at day 0, 3, and 7 were added to 25 lL of 2
mM p-aminophenylmercuric acetate solution and incubated at
378C for 3 hours. MMP red substrate (50 lL) was then added
and the mix was incubated at room temperature for 1 hour.
Fluorescence was measured at Ex/Em¼540/590 nM (FLUOstar
Optima; BMG LABTECH).
Statistical Analysis
All graphs display mean and standard error. Statistical analysis
was performed using the Students t-test to establish significant
differences and individual P values displayed.
RESULTS
Doxycycline Prevents Collagen Matrix Remodeling
and Contraction by Trichiasis Fibroblasts
We used our well-characterized in vitro model of cell-mediated
matrix contraction8,23–26 to assess the contractile potential of
primary fibroblasts isolated from the conjunctiva of patients
with trachomatous trichiasis and evaluate the potential of
doxycycline as a modulator of contraction. As expected from
their conjunctival and fibrotic origin,23,25 trichiasis fibroblasts
(F07, F09, F10, and F11) contracted collagen matrices strongly,
down to 20% to 30% of their original size over 7 days in the
presence of 10% serum. The application of 104 lM doxycy-
cline for 7 days was sufficient to reduce matrix contraction by
25% and more significantly, a 7-day treatment with 416 lM
doxycycline prevented the contraction by up to 75% (Fig. 1A).
Figures 1B and 1C show two representative contraction
kinetics from F10 and F11 fibroblast lines, illustrating that
doxycycline treatment reduced gel contraction as early as at
day 1, with the effect of the drug increasing with incubation
time for the higher concentration. To confirm that this effect
was not due to drug toxicity, an LDH assay was performed on
the cells within collagen gels following a 7-day doxycycline
treatment at 104 or 416 lM. We found no detectable toxicity
effect for the drug at either concentration (Fig. 1D).
We have shown previously that fibroblast-mediated gel
contraction is dependent on the ability of the cells to affect the
organization of pericellular collagen fibers through both direct
mechanical pulling on the fibers to align and compact them, as
well as by matrix degradation through the release of
MMPs.23,24 To determine how doxycycline prevented gel
contraction, we used confocal microscopy to assess cell
morphology and pericellular matrix organization in the gels
following doxycycline treatment. As all four cell lines behaved
identically in terms of matrix contraction and response to
doxycycline (data not shown), we selected two representative
cell lines, F10 and F11, to perform these studies and further
work. Trichiasis-derived fibroblasts had a stellate appearance in
the gels, with long F-actin rich protrusions, as illustrated by the
full projection of the cell volume23 (Fig. 2, red staining). In
agreement with the toxicity data, the overall morphology of
the cells appeared unaltered by the doxycycline treatment.
Consistent with our previous work on other types of
fibroblasts, the high contractile profile of the trichiasis
FIGURE 1. Doxycycline treatment prevents collagen matrix contraction by trichiasis fibroblasts. (A) Effect of doxycycline on trichiasis fibroblasts
(pooled data for F07, F09, F10, and F11) gel contraction at day 7. Each data point was averaged from triplicate gels, n¼3. *P < 0.05. **P < 0.01. ***P
< 0.001. (B, C) Representative collagen gel contraction profile for F10 and F11 (mean 6 SEM, three gels each). (D) Cytotoxicity as measured by LDH
activity release into the medium during contraction after 7 days. The data is shown as percentage cell survival (mean6 SEM, for n¼ three gels each).
Doxycycline Prevents Matrix Remodeling IOVS j July 2013 j Vol. 54 j No. 7 j 4677
Downloaded From: http://iovs.arvojournals.org/pdfaccess.ashx?url=/data/journals/iovs/932985/ on 10/09/2017
fibroblasts was linked to extensive remodeling and degradation
of the collagen matrix by day 7, as visualized by a lack of
distinct collagen fibers following confocal reflection imag-
ing.8,23 Areas of dense, compacted, poorly resolved collagen
clumps could be seen as a bright white aura around the cells
(Fig. 2, arrows), while the rest of the matrix shows a fuzzy
appearance, characteristic of MMP-mediated degradation.23 By
contrast, in presence of 416 lM doxycycline, the matrix fibers
remained clearly defined and evidence of fiber alignment
consecutive to active cell pulling on the matrix can be found
surrounding most of the cells (Fig. 2, arrowhead).
Doxycycline Reduces MMP Expression During
Collagen Matrix Contraction
Our morphological analysis of the cells and matrix during
contraction strongly suggested that doxycycline could act
through a modulation of matrix degradation and thus likely
MMP release. MMPs have long been connected to scarring
processes. We have previously shown that matrix remodeling
by MMPs plays an important role in tissue contraction, both in
in vitro,8,23 ex vivo,8 as well as in an ocular scarring model in
the rabbit model of glaucoma filtration surgery.27 In addition,
our recent studies have suggested a role for MMPs in the
development of the fibrotic phenotype in trachoma.10,11 We
thus used real-time PCR to evaluate MMP expression during
matrix contraction. We chose to investigate levels of MMP1 as a
well-known collagenase previously implicated in our standard
collagen contraction assay26; MMP2 as a standard gelatinase;
and MMP7, MMP9, and MMP12 as these particular MMPs have
been found enriched in trichiasis samples.12 The CT values
from the RT-PCR study demonstrated that all of the above
MMPs were present in both F10 and F11 at day 0. MMP1 and
MMP2 were expressed at significant levels, while MMP7 and
MMP9 were naturally low (Table). All MMPs showed an
increased expression during contraction in the control group,
although to a different extent and kinetics. While MMP1,
MMP2, and MMP12 showed a sustained increase throughout
the contraction kinetics, MMP9 expression peaked at day 3
(Fig. 3). Continuous treatment with 416 lM doxycycline did
not significantly affect MMP2 expression (Figs. 3C, 3D).
However, MMP1 (Figs. 3A, 3B), MMP9 (Fig. 3E, 3F), and
MMP12 (Figs. 3G, 3H) all show a strong reduction in
expression in the presence of the drug. We also observed a
similar trend for MMP7 in F10 (Table, normalized expression
data not shown), but could not confirm this effect in F11 due
to its lower expression of MMP7 and the technical limitation of
RT-PCR. To confirm that the effect of doxycycline on MMP
gene expression led to a reduction in protein expression and
activity, we measured the total MMP activity released in the
medium during contraction. As expected, the total MMP
activity releasable from the medium increased significantly
during contraction, particularly in F10, matching the gene
expression profile (Fig. 4). Treatment with doxycycline
completely abrogated MMP activity, even in medium at day 0,
suggesting that doxycycline affected both the MMP protein
levels and the activity of the MMPs present in the medium.
DISCUSSION
Using our in vitro model of cell-mediated matrix contrac-
tion,8,23–26 we found that doxycycline significantly reduced the
contractile potential of primary fibroblasts isolated from the
conjunctiva of patients with trachomatous trichiasis, while
presenting only minimal toxicity. This low toxicity and strong
effect on contraction compares favorably with previously
studied inhibitors of matrix contraction targeting cell divi-
sion,28 matrix metalloproteinase activity,8,23,29 or small Rho
GTPases,26 which have been found to prevent tissue contrac-
tion ex vivo26,29 and scarring in vivo, both in animal models27
and in the clinic.30,31 Our results suggest that doxycycline’s
effect on contraction is at least partly mediated by its ability to
inhibit MMP expression and activity, which we have shown is a
major component of the contraction process.8,23,26 In addition,
doxycycline appears to selectively target the expression of
MMP1, MMP7, MMP9, and MMP12, which have been linked to
the fibrotic phenotype in trachoma. Doxycycline has previ-
ously been shown to both reduce MMPs expression levels32,33
and affect MMP activity.13,19,33 In particular, it reduced MMP2
and MMP9 activity during gel contraction in vitro34 and fibrosis
in vivo,35 suggesting that doxycycline’s effects on MMP
underlies at least part of its strong effect on matrix remodeling
in trachoma. While the doxycycline inhibition of MMP activity
is known to involve zinc chelation, the mechanism by which
doxycycline affects MMP gene expression is still unclear.
However, as doxycycline appears to broadly affect the
proinflammatory response, it could affect MMP expression
through a downregulation of MMP-inducing proinflammatory
cytokines.21,22,32
MMP1, one of the main collagenases, has been linked to
pathological processes such as fibrotic diseases and cancer.36
Although it has not been reported in association with trichiasis,
our previous work with human tenons’ capsule fibroblasts has
shown that it is heavily expressed during matrix contraction in
vitro and its reduction is linked to a decrease in contraction,26
suggesting that it may also functionally facilitate the matrix
remodeling process during trichiasis. MMP7 is expressed in
epithelia and injured tissue. It plays an important role in
inflammation.37,38 MMP7 upregulation not only participates in
ECM regulation, but also correlates with many fibrotic
FIGURE 2. Doxycycline treatment prevents matrix degradation and
remodeling. Trichiasis fibroblasts F10 and F11 were embedded in
collagen gels in medium with/without 416 lM doxycycline. The gels
were fixed and stained with rhodamine phalloidin after 7 days. Shown
are representative images of cells embedded in the matrix: red, two-
dimensional projection of the full cell F-actin volume; white, collagen
matrix fibers viewed using confocal reflection microscopy. Arrows
show pericellular collagen fibers compaction. Arrowhead radial
alignment consecutive to cell dynamic activity. Scale bar, 10 lm.
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diseases,39 including trachoma11 and tumor metastasis.40
MMP9 is a major component of ECM turnover during
homeostasis and conjunctival scarring,41 and its expression is
closely linked to the degree of inflammation in the human
conjunctival epithelium of children with active trachoma.42,43
We found here that trichiasis-derived fibroblasts express low
levels of MMP7 and MMP9. However, both MMP levels are
increased transiently during the contraction process, suggest-
FIGURE 3. Doxycycline inhibits MMP expression during contraction. Quantitative RT-PCR for MMP1 (A, B), MMP2 (C, D), MMP9 (E, F), and MMP12
(G, H) mRNA expression in trichiasis fibroblasts F10 and F11 during contraction with/without 416 lM doxycycline. Significant differences in
expression during contraction with reference to the value at day 0 are expressed as *P < 0.05. **P < 0.01. ***P < 0.001. Significant differences
between control and treated samples on the same day are expressed as þP < 0.05, þþP < 0.01, þþþP < 0.001 (mean 6 SEM, n ¼ three repeats).
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ing that these MMPs may be functional and activated mostly at
the initial stage. The extremely low expression of MMP7 in F11
might be the result of the natural biological variation of F11,
together with the technical limit of semi-quantitative RT-PCR.
MMP12, on the other hand, is mainly produced by macro-
phages, its main function including degrading elastin and
taking part in proinflammatory processes.44 Increased MMP12
expression has been reported in the scarred conjunctiva of
people with trichiasis either with or without inflammation.12
Our results showed MMP12 has a modest but consistent
increasing during the matrix contraction both in F10 and F11,
suggesting that it could directly contribute to matrix remod-
eling in trichiasis. Interestingly, though doxycycline treatment
was shown to significantly inhibit MMP12 expression in both
cell lines studied, it was significantly more efficient in
preventing the contraction of F11, which did not express
significant levels of MMP7 and MMP9. This suggests that in the
absence of MMP7 and MMP9, MMP12 might be a significant
factor driving trichiasis fibroblast-mediated contraction.
Doxycycline’s potential as an MMP inhibitor has been
extensively documented and it has proved useful in clinical
settings,14,20 with many reporting its strong effect on
MMP9.13,14,19 Recent work suggests that it can also modulate
inflammation,21,22 thus making it a good candidate to prevent
the immunofibrogenic process that underlies recurrent tracho-
matous trichiasis. We present here evidence that doxycycline
FIGURE 4. Doxycycline inhibits MMP activity during contraction. The
total MMP activity released in the medium by F10 and F11 cells with/
without doxycycline treatment was measured at day 0, 3, and 7 during
contraction using a FRET-based assay. MMP activity is expressed as
fluorescence levels (mean 6 SEM; F10, n ¼ 3; F11, n ¼ 2).
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prevents matrix remodeling and contraction by trichiasis-
derived fibroblasts and leads to a significant downregulation in
MMP expression in these cells. The in vitro model of tissue
contraction used here has already proved essential to the
development of treatments for the prevention of scarring
following glaucoma filtration surgery and a reasonable
predictor of the clinical potential of anti-scarring treatments.30
In the absence of any animal model for trichiasis development
and recurrence, this in vitro model may facilitate the
translational pathway to modeling the pathogenesis of
trachoma and evaluating the effectiveness of new treatments
in advance of clinical trials. In view of our results and the wider
use of doxycycline in clinical settings, we propose that
doxycycline might be useful as a treatment to prevent
recurrence following trichiasis surgery.
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